KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Debt Ratio (2016 - 2020)

Neogenomics' Debt Ratio history spans 11 years, with the latest figure at 0.13 for Q1 2020.

  • For Q1 2020, Debt Ratio fell 25.82% year-over-year to 0.13; the TTM value through Mar 2020 reached 0.13, down 25.82%, while the annual FY2019 figure was 0.14, 435.39% up from the prior year.
  • Debt Ratio reached 0.13 in Q1 2020 per NEO's latest filing, down from 0.14 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.22 in Q4 2016 to a low of 0.01 in Q2 2019.
  • Average Debt Ratio over 5 years is 0.13, with a median of 0.14 recorded in 2019.
  • The largest YoY upside for Debt Ratio was 780.38% in 2019 against a maximum downside of 93.06% in 2019.
  • A 5-year view of Debt Ratio shows it stood at 0.22 in 2016, then dropped by 6.81% to 0.2 in 2017, then tumbled by 87.52% to 0.03 in 2018, then soared by 435.39% to 0.14 in 2019, then dropped by 4.33% to 0.13 in 2020.
  • Per Business Quant, the three most recent readings for NEO's Debt Ratio are 0.13 (Q1 2020), 0.14 (Q4 2019), and 0.14 (Q3 2019).